-+ 0.00%
-+ 0.00%
-+ 0.00%

OUTLOOK THERAPEUTICS REPORTS THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE HIGHLIGHTING FDA APPROVAL OF LYTENAVA™

Reuters·08/14/2026 11:15:00

Please log in to view news